Cita APA (7a ed.)
Zheng, Y., Fu, Y., Chen, Y., Li, Q., Liu, T., & Ding, Z. (2023). Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion. Current Oncology, 30(11), 9929-9940.
Cita Chicago Style (17a ed.)
Zheng, Yue, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, y Zhenyu Ding. "Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion." Current Oncology 30, no. 11 (2023): 9929-9940.
Cita MLA (9a ed.)
Zheng, Yue, et al. "Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion." Current Oncology, vol. 30, no. 11, 2023, pp. 9929-9940.
Precaución: Estas citas no son 100% exactas.